Effect of methylprednisolone in patients with Guillain-Barré syndrome.
Rossi
Gabriele
G
Locatelli
Franco
F
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage*; D020275:Guillain-Barre Syndrome / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D008775:Methylprednisolone / Q000008:administration & dosage*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D000069283:Rituximab; D008775:Methylprednisolone